🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/04/2018 | 111,98 | 118,25 | 110,97 | 115,77 | +7,77% | 6,50% | 713.400 |
| 02/04/2018 | 111,59 | 111,59 | 106,86 | 107,42 | -4,40% | 4,24% | 466.100 |
| 29/03/2018 | 110,70 | 112,87 | 109,45 | 112,36 | +1,68% | 3,09% | 369.300 |
| 28/03/2018 | 108,65 | 111,46 | 108,51 | 110,50 | +3,07% | 2,72% | 401.400 |
| 27/03/2018 | 109,30 | 109,84 | 106,91 | 107,21 | -2,00% | 2,68% | 367.600 |
| 26/03/2018 | 108,73 | 109,94 | 106,80 | 109,40 | +1,87% | 2,89% | 374.400 |
| 23/03/2018 | 108,67 | 110,00 | 107,11 | 107,39 | -0,95% | 2,66% | 301.200 |
| 22/03/2018 | 108,18 | 110,28 | 106,30 | 108,42 | -0,59% | 3,68% | 305.600 |
| 21/03/2018 | 107,22 | 109,95 | 106,81 | 109,06 | +1,25% | 2,93% | 331.500 |
| 20/03/2018 | 110,52 | 111,01 | 107,29 | 107,71 | -2,12% | 3,37% | 398.100 |
| 19/03/2018 | 110,63 | 112,71 | 108,64 | 110,04 | -0,99% | 3,68% | 386.900 |
| 16/03/2018 | 111,04 | 112,31 | 110,40 | 111,14 | +0,13% | 1,72% | 613.300 |
| 15/03/2018 | 112,33 | 112,33 | 109,93 | 111,00 | -0,79% | 2,14% | 363.000 |
| 14/03/2018 | 113,85 | 114,61 | 111,62 | 111,88 | -1,76% | 2,63% | 373.700 |
| 13/03/2018 | 115,42 | 116,64 | 113,00 | 113,89 | -1,88% | 3,15% | 288.900 |
| 12/03/2018 | 115,42 | 116,64 | 114,56 | 116,07 | +0,63% | 1,80% | 342.400 |
| 09/03/2018 | 115,65 | 116,36 | 113,54 | 115,34 | -0,02% | 2,44% | 366.500 |
| 08/03/2018 | 110,64 | 118,44 | 109,98 | 115,36 | +4,85% | 7,65% | 630.700 |
| 07/03/2018 | 111,46 | 112,73 | 107,82 | 110,02 | -2,44% | 4,41% | 681.300 |
| 06/03/2018 | 111,00 | 112,87 | 108,65 | 112,77 | +2,11% | 3,80% | 473.100 |
| 05/03/2018 | 112,89 | 113,67 | 110,15 | 110,44 | -2,94% | 3,12% | 352.700 |
| 02/03/2018 | 113,14 | 115,78 | 111,55 | 113,79 | +0,20% | 3,74% | 369.500 |
| 01/03/2018 | 115,52 | 116,91 | 111,11 | 113,56 | -1,98% | 5,02% | 570.300 |
| 28/02/2018 | 115,78 | 116,66 | 114,75 | 115,85 | +0,70% | 1,65% | 635.200 |
| 27/02/2018 | 115,71 | 118,06 | 113,49 | 115,05 | -0,78% | 3,95% | 484.700 |
| 26/02/2018 | 117,45 | 117,68 | 113,12 | 115,96 | -1,76% | 3,88% | 505.400 |
| 23/02/2018 | 118,82 | 119,20 | 115,71 | 118,04 | +0,42% | 2,94% | 411.700 |
| 22/02/2018 | 122,08 | 124,99 | 115,12 | 117,55 | -3,78% | 8,08% | 1.086.600 |
| 21/02/2018 | 134,30 | 134,30 | 120,68 | 122,17 | -9,48% | 10,14% | 1.675.100 |
| 20/02/2018 | 133,81 | 139,54 | 133,65 | 134,96 | +0,02% | 4,40% | 545.800 |